Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Calgary

$135,000.00

Understanding the role of invariant natural killer T cells in the lung during infection, sterile inflammation, and their interplay.

EF 2012-13

Résumé
Respiratory diseases will be the fourth leading cause of death worldwide by 2020. Yet our ability to visualize the lung parenchyma and vasculature at the single cell level has lagged behind most other organs. As such what is common knowledge in some tissues remains a mystery in lung. In collaboration with Dr. Krummel at UCSF, the Kubes laboratory has recently developed a novel way of imaging the lung to have single-cell resolution. Using this approach we will begin to elucidate some of the fundamental issues regarding the immune system in the lung. Invariant natural killer T (iNKT) cells are extremely important cells in immunity because they bear characteristics of innate and adaptive lymphocytes, which allow them to dictate whether an immune response to infection or to an allergen is established. As such they are being implicated to play important roles in many diseases including allergic asthma, chronic obstructive pulmonary disease, and during lung infections. We recently uncovered that in the liver under basal conditions, iNKT cells constantly patrol the liver microvasculature, living inside the blood vessels. During infection macrophages in the liver catch the bacteria and present antigen via CD1d to iNKT cells, which activate the immune system. However, it remains completely unclear 1) where the iNKT cells reside in lung, 2) whether they can be presented with antigens and if so by which cells, and 3) what role iNKT cells play during bacterial lung infections with Streptococcus pneumoniae or during sterile lung injury like in the case of idiopathic pulmonary fibrosis (IPF). In this study we will use our newly developed live imaging technique to address these issues and understand the role of iNKT cells during lung disease. We believe that this work will lead to important insights into how the lung responds to injury and infection. Furthermore this work will provide potential clues for novel therapeutics against currently untreatable lung diseases such as IPF
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
280883
Name
Thanabalasuriar Ajitha
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Understanding the role of invariant natural killer T cells in the lung during infection, sterile inflammation, and their interplay.
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Intravital Microscopy; Invariant Natural Killer T Cells; Pulmonary Fibrosis; Pulmonary Infection; Pulmonary Injury; Spinning Disk Confocal Microscopy
Abstract
Respiratory diseases will be the fourth leading cause of death worldwide by 2020. Yet our ability to visualize the lung parenchyma and vasculature at the single cell level has lagged behind most other organs. As such what is common knowledge in some tissues remains a mystery in lung. In collaboration with Dr. Krummel at UCSF, the Kubes laboratory has recently developed a novel way of imaging the lung to have single-cell resolution. Using this approach we will begin to elucidate some of the fundamental issues regarding the immune system in the lung. Invariant natural killer T (iNKT) cells are extremely important cells in immunity because they bear characteristics of innate and adaptive lymphocytes, which allow them to dictate whether an immune response to infection or to an allergen is established. As such they are being implicated to play important roles in many diseases including allergic asthma, chronic obstructive pulmonary disease, and during lung infections. We recently uncovered that in the liver under basal conditions, iNKT cells constantly patrol the liver microvasculature, living inside the blood vessels. During infection macrophages in the liver catch the bacteria and present antigen via CD1d to iNKT cells, which activate the immune system. However, it remains completely unclear 1) where the iNKT cells reside in lung, 2) whether they can be presented with antigens and if so by which cells, and 3) what role iNKT cells play during bacterial lung infections with Streptococcus pneumoniae or during sterile lung injury like in the case of idiopathic pulmonary fibrosis (IPF). In this study we will use our newly developed live imaging technique to address these issues and understand the role of iNKT cells during lung disease. We believe that this work will lead to important insights into how the lung responds to injury and infection. Furthermore this work will provide potential clues for novel therapeutics against currently untreatable lung diseases such as IPF
Competitiondate
201302
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Thanabalasuriar, Ajitha
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~